Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

'Triple pill' lowers blood pressure compared to traditional therapy

A drug therapy containing low doses of three different blood pressure-lowering medications, also known as the “Triple Pill,” decreased blood pressure targets compared with traditional drug treatment. Researchers highlighted the efficacy of the pill when presenting their findings at the American College of Cardiology's 67th Annual Scientific Session in Orlando on March 12.

New $1 million research initiative supports early career vascular disease investigator research

The American Heart Association and VIVA Physicians, Inc. announced today a two-year $1 million grant program to support research initiatives in vascular disease and career development opportunities for early career investigators at the post-doctoral level.

Study to determine whether stem cell therapy can boost defective hearts

Researchers at the University of Maryland Medical Center are investigating whether a stem cell treatment can improve outcomes for children born with hypoplastic left heart syndrome, in which the left half of the heart is unable to pump blood.

No significant differences in efficacy, safety between drug-eluting stents

There are few significant differences in target-vessel failure with second generation drug-eluting stents (DES) for patients with left main coronary artery disease (LMCAD), according to research published on Feb. 27 in the Journal of the American College of Cardiology.

Anti-inflammatory canakinumab fails to prevent progression to diabetes

The anti-inflammatory drug canakinumab failed to halt the progression from prediabetes to diabetes, according to an analysis of the CANTOS trial presented March 11 at the American College of Cardiology’s annual scientific session.

Thumbnail

Barbershops a prime location for blood pressure interventions among black men

Researchers may have identified a promising setting to control hypertension among black men—a group with an inordinate burden of high blood pressure and related adverse events. By bringing specialty care to the community through black-owned barbershops, Ronald G. Victor, MD, and colleagues showed substantial blood pressure reductions can be achieved within six months.

Thumbnail

VEST trial falls short, fails to reduce sudden death rates with wearable defibrillator

The VEST study—an effort to reduce post-myocardial infarction (MI) mortality and one of ACC 18’s most anticipated clinical trials—failed to meet its primary endpoint of reducing sudden death due to ventricular arrhythmias, study leader Jeffrey Olgin, MD, announced to a crowd of thousands following ACC’s opening ceremony Saturday.

Texas to start monitoring waist sizes of state troopers

The Texas Department of Public Safety (TxDPS) is now recording the height, weight and waist measurement of its more than 4,200 troopers.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.